 MIAMI, March 15, 2022 GLOBE NEWSWIRE -- Longeveron Inc. NASDAQ: LGVN Longeveron or Company, a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Geoff Green, Chief Executive Officer at Longeveron, will present at the upcoming Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022. Details of Longeverons participation follow below: 